March 15, 2019
TUESDAY, March 12, 2019 (The New York Times)—Dr. Norman E. (Ned) Sharpless, director of the National Cancer Institute, will serve as acting commissioner of the Food and Drug Administration, Alex M. Azar III, secretary of health and human services, announced on Tuesday.
Dr. Sharpless temporarily will fill the post being vacated by Dr. Scott Gottlieb, who stunned public health experts, lawmakers and consumer groups last week when he abruptly announced that he was resigning for personal reasons.
FDA proposes e-cigarette sale restrictions to curb teen vaping
Mar. 13, USA Today
Paul Talalay, researcher who found cancer-preventing qualities in broccoli, dies at 95
Mar. 13, The Washington Post
HPV Strikes Men as Well as Women
Mar. 8, Voice of America
Did You Wait Until Middle Age to Get Fit? It Could Still Boost Your Life Span
Mar. 8, U.S. News & World Report